Tinnitus — Treating Tinnitus Using the Neuromonics Tinnitus Treatment Program: A Randomized, Double-blind Study
Citation(s)
Bauer CA, Brozoski TJ Effect of gabapentin on the sensation and impact of tinnitus. Laryngoscope. 2006 May;116(5):675-81.
Davis PB, Paki B, Hanley PJ Neuromonics Tinnitus Treatment: third clinical trial. Ear Hear. 2007 Apr;28(2):242-59.
Davis PB, Wilde RA, Steed LG, Hanley PJ Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study. Ear Nose Throat J. 2008 Jun;87(6):330-9.
Davis, P B., Music and the acoustic desensitization protocol for tinnitus., in Tinnitus treatments R.S. Tyler, Editor. 2005, Thieme: New York.
Davis, P B., R.A. Wilde, and L.G. Steed. Clinical trial findings of a neurophysiologically-based tinnitus rehabilitation technique using tinnitus desensitization music. in Proceedings of the Seventh International Tinnitus Seminar. 2002. Perth: University of Western Australia.
Dineen R, Doyle J, Bench J, Perry A The influence of training on tinnitus perception: an evaluation 12 months after tinnitus management training. Br J Audiol. 1999 Feb;33(1):29-51.
Hanley PJ, Davis PB, Paki B, Quinn SA, Bellekom SR Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice. Ann Otol Rhinol Laryngol. 2008 Nov;117(11):791-9.
Henry, J A., et al., Tinnitus retraining therapy and masking; how do they compare?, in Proceedings of the Seventh International Tinnitus Seminar, R. Patuzzi, Editor. 2002, Hawthorn Production Services: Norfolk, VA. p. 247-254.
Hiller W, Haerkötter C Does sound stimulation have additive effects on cognitive-behavioral treatment of chronic tinnitus? Behav Res Ther. 2005 May;43(5):595-612.
Jastreboff PJ, Hazell JW A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993 Feb;27(1):7-17. Review.
Karch, S J., Hill, M. M., Casto, K. L., Nedostup, A. E., & Staton, R. N. (2014). Evaluation of Sound Therapy Tinnitus Treatments with Concurrent Counseling in Active Duty Military Personnel. (Report 2014-022). Fort Rucker, AL: U.S. Army Aeromedical Research Laboratory.
Karch, S J., et al., Evaluation of Sound Therapy Tinnitus Treatments with Concurrent Counseling in Active Duty Military Personnel. 2014, U.S. Army Aeromedical Research Laboratory: Fort Rucker, AL.
McKinney, C J., J.W. Hazell, and R.L. Graham, An evaluation of the TRT method, in Proceedings of the sixth international tinnitus seminar, J.W. Hazell, Editor. 1999. p. 99-105.
Schmitt, C and B. Kroner-Herwig, Comparison of tinnitus coping training and TRT: Are they superior to education?, in Proceedings of the Seventh International Tinnitus Seminar, R. Patuzzi, Editor. 2002, Hawthorn Production Services: Norfolk, VA. p. 273-276.
Tyler, R S., Final Report: A preliminary investigation of the effectiveness of tinnitus retraining therapy. Tinnitus Today, 2004. 29: p. 12.
Tyler, R S., Neurophysiological models, psychological models, and treatments for tinnitus, in Tinnitus Treatments: Clinical Protocols, R.S. Tyler, Editor. 2005, Thieme Medical Publishers: New York. p. 1-22.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
